Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure

This publication has 5 references indexed in Scilit:

• Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
  The Lancet, 2002
• Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension
  Circulation, 2002
• Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension
  Annals of Internal Medicine, 2002
• Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension
  Critical Care Medicine, 2001
• Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro
  The American Journal of Cardiology, 1999